About FDA
Percentage of NDI notification reviews completed during the month within 75 days of filing
Dictionary: Timely review of notifications of new dietary ingredients impacts the public health by preventing substances that are not actually dietary ingredients from being used in dietary supplements, and assuring that new dietary ingredients have adequate evidence for presumption of safety. Since these statutory requirements are notifications rather than pre-market approvals, it is essential that ONLDS have completed review of the information before the submitter markets the product, to notify them of any safety or regulatory concerns before the product reaches consumers.
Information is current as of December 31, 2012.
Fiscal Year - 2012
| Time | Annual Target | Percentage |
|---|---|---|
| Oct 2011 | 90 | 100 |
| Nov 2011 | 90 | 100 |
| Dec 2011 | 90 | 100 |
| Jan 2012 | 90 | 100 |
| Feb 2012 | 90 | 100 |
| Mar 2012 | 90 | 100 |
| Apr 2012 | 90 | 100 |
| May 2012 | 90 | 100 |
| Jun 2012 | 90 | 100 |
| Jul 2012 | 90 | 100 |
| Aug 2012 | 90 | 100 |
| Sep 2012 | 90 | 100 |
FY 2012 Overall: 100%
Number of NDI notification reviews due to be completed during the month
Fiscal Year - 2012
| Time | Target | Number |
|---|---|---|
| Oct 2011 | N/A | 3 |
| Nov 2011 | N/A | 5 |
| Dec 2011 | N/A | 4 |
| Jan 2012 | N/A | 2 |
| Feb 2012 | N/A | 4 |
| Mar 2012 | N/A | 3 |
| Apr 2012 | N/A | 6 |
| May 2012 | N/A | 2 |
| Jun 2012 | N/A | 4 |
| Jul 2012 | N/A | 6 |
| Aug 2012 | N/A | 3 |
| Sep 2012 | N/A | 3 |
FY 2012 Total: 45
Number of NDI notification reviews completed during the month within 75 days of filing
Fiscal Year - 2012
| Time | Target | Number |
|---|---|---|
| Oct 2011 | N/A | 3 |
| Nov 2011 | N/A | 5 |
| Dec 2011 | N/A | 4 |
| Jan 2012 | N/A | 2 |
| Feb 2012 | N/A | 4 |
| Mar 2012 | N/A | 3 |
| Apr 2012 | N/A | 6 |
| May 2012 | N/A | 2 |
| Jun 2012 | N/A | 4 |
| Jul 2012 | N/A | 6 |
| Aug 2012 | N/A | 3 |
| Sep 2012 | N/A | 3 |
FY 2012 Total: 45
Total number of NDI notification reviews completed during the month
Fiscal Year - 2012
| Time | Target | Number |
|---|---|---|
| Oct 2011 | N/A | 3 |
| Nov 2011 | N/A | 5 |
| Dec 2011 | N/A | 4 |
| Jan 2012 | N/A | 2 |
| Feb 2012 | N/A | 4 |
| Mar 2012 | N/A | 3 |
| Apr 2012 | N/A | 6 |
| May 2012 | N/A | 2 |
| Jun 2012 | N/A | 4 |
| Jul 2012 | N/A | 6 |
| Aug 2012 | N/A | 3 |
| Sep 2012 | N/A | 3 |
FY 2012 Total: 45
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
